New combo shows promise for tough lung cancers
Disease control
Completed
This study tested a combination of two drugs—pembrolizumab (an immunotherapy) and Imprime PGG (a yeast-based immune booster)—in 35 adults with advanced non-small cell lung cancer that had worsened after initial therapy. The goal was to see if the combo could shrink tumors or slow…
Phase: PHASE1, PHASE2 • Sponsor: Lawrence Feldman, MD • Aim: Disease control
Last updated May 13, 2026 15:59 UTC